This course aims to provide state-of-the-art education for neurologists and neurologists-in-training in China. Furthermore, the course provides access to leading academic neurology researchers in Australia and has been designed to foster research and clinical collaboration between Chinese and Australian neurologists, Chinese and Australian Hospitals and with the soon to be completed Parkville Neuroscience Facility.
The course is delivered over two weeks; the first week in China (Shanghai), the second in Australia (Melbourne).
At the end of the second week, attendees undergo a formal assessment designed to provide attendees with feedback as to the extent to which they are utilising the most advanced neurological treatment to achieve improvement of clinical performance. On successful completion of the assessment, a Certificate of Attainment is provided by the University of Melbourne.
CSL and Bayer, through their commitment to professional development in clinical neurology, provide sponsorship for this course to offset the tuition costs.View full details